8,031 reports of this reaction
2.3% of all CLONAZEPAM reports
#7 most reported adverse reaction
PAIN is the #7 most commonly reported adverse reaction for CLONAZEPAM, manufactured by H2-Pharma, LLC. There are 8,031 FDA adverse event reports linking CLONAZEPAM to PAIN. This represents approximately 2.3% of all 346,085 adverse event reports for this drug.
Patients taking CLONAZEPAM who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is a less commonly reported adverse event for CLONAZEPAM, but still significant enough to appear in the safety profile.
In addition to pain, the following adverse reactions have been reported for CLONAZEPAM:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 8,031 FDA reports for CLONAZEPAM. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 2.3% of all adverse event reports for CLONAZEPAM, making it a notable side effect.
If you experience pain while taking CLONAZEPAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.